Unknown

Dataset Information

0

Desymmetrization of pibrentasvir for efficient prodrug synthesis.


ABSTRACT: A novel and practical desymmetrization tactic is described to access a new class of pibrentasvir prodrugs. The homotopic benzimidazoles of pibrentasvir (PIB) are differentiated via a one-pot di-Boc/mono-de-Boc selective N-Boc protection and formaldehyde adduct formation sequence, both enabled by crystallization-induced selectivity. The first step represents the only known application of the Horeau principle of statistical amplification for C 2-symmetric polyheterocycle regioselective functionalization. The resulting versatile intermediate is employed in the high-yielding preparation of several pibrentasvir prodrug candidates.

SUBMITTER: Voight EA 

PROVIDER: S-EPMC8317637 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2529399 | biostudies-literature
| S-EPMC3633631 | biostudies-literature
| S-EPMC5960067 | biostudies-literature
| S-EPMC5526648 | biostudies-literature
| S-EPMC4422513 | biostudies-literature
| S-EPMC5802806 | biostudies-other
| S-EPMC4409926 | biostudies-literature
| S-EPMC2701296 | biostudies-literature
| S-EPMC3964814 | biostudies-literature
| S-EPMC8796237 | biostudies-literature